Evolution of Angiogenic Factors in Pregnant Patients with Breast Cancer Treated with Chemotherapy

Evolution of Angiogenic Factors in Pregnant Patients with Breast Cancer Treated with Chemotherapy

High prevalence of placental-derived complications, such as preeclampsia and intrauterine growth restriction, has been reported in women with breast cancer (BC) treated with chemotherapy during pregnancy (PBC-CHT). Aim: To ascertain whether PBC-CHT is associated with an imbalance of angiogenic facto...

Full description

Bibliographic Details
Main Authors: Cristina Saura, Olga Sánchez, Sandra Martínez, Carmen Domínguez, Rodrigo Dienstmann, Fiorella Ruíz-Pace, Maria Concepció Céspedes, Ángeles Peñuelas, Javier Cortés, Elisa Llurba, Octavi Córdoba
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Cancers
Subjects:
breast cancer
pregnancy
angiogenic factors
chemotherapy
Online Access:https://www.mdpi.com/2072-6694/13/4/923

Internet

https://www.mdpi.com/2072-6694/13/4/923

Similar Items